Article
Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Estimation Using Commercial Laboratory Specimens: How Representative Is It of the General U.S. Pediatric Population?
2022-05-04
Abstract excerpt
Background and Objectives<br>Since August 2020, a national U.S. study has estimated infection-induced SARS-CoV-2 seroprevalence. Because this study uses sera collected by commercial laboratories and most children do not require frequent laboratory testing, we investigated the representativeness of U.S. pediatric seroprevalence estimates.<br><br>Methods<br>Repeated, cross-sectional, convenience samples of residual...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7eb8b310-4880-51a7-be82-7ed03bc9b00b
- DOI
- 10.2139/ssrn.4092074
